DK0722736T3 - Topisk sammensætning indeholdende en antagonist for substans P - Google Patents

Topisk sammensætning indeholdende en antagonist for substans P

Info

Publication number: DK0722736T3
Authority: DK; Denmark
Prior art keywords: antagonist; substance; composition containing; topical composition; topical
Prior art date: 1994-12-19

Application number

DK95402502T

Other languages

English (en)

Inventor

Lacharriere Olivier De

Lionel Breton

Original Assignee

Oreal

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-12-19

Filing date

1995-11-09

Publication date

2001-04-02

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=9469931&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK0722736(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1995-11-09 Application filed by Oreal filed Critical Oreal

2001-04-02 Application granted granted Critical

2001-04-02 Publication of DK0722736T3 publication Critical patent/DK0722736T3/da

Links

QDZOEBFLNHCSSF-PFFBOGFISA-N (2S)-2-[[(2R)-2-[[(2S)-1-[(2S)-6-amino-2-[[(2S)-1-[(2R)-2-amino-5-carbamimidamidopentanoyl]pyrrolidine-2-carbonyl]amino]hexanoyl]pyrrolidine-2-carbonyl]amino]-3-(1H-indol-3-yl)propanoyl]amino]-N-[(2R)-1-[[(2S)-1-[[(2R)-1-[[(2S)-1-[[(2S)-1-amino-4-methyl-1-oxopentan-2-yl]amino]-4-methyl-1-oxopentan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]pentanediamide Chemical compound C([C@@H](C(=O)N[C@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](CCCCN)NC(=O)[C@H]1N(CCC1)C(=O)[C@H](N)CCCNC(N)=N)C1=CC=CC=C1 QDZOEBFLNHCSSF-PFFBOGFISA-N 0.000 title 1
102100024304 Protachykinin-1 Human genes 0.000 title 1
101800003906 Substance P Proteins 0.000 title 1
239000005557 antagonist Substances 0.000 title 1
230000000699 topical effect Effects 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/203—Retinoic acids ; Salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/046—Tachykinins, e.g. eledoisins, substance P; Related peptides
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Dermatology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Gastroenterology & Hepatology (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Medicinal Preparation (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Cosmetics (AREA)

DK95402502T 1994-12-19 1995-11-09 Topisk sammensætning indeholdende en antagonist for substans P DK0722736T3 (da)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
FR9415253A FR2728166A1 (fr)	1994-12-19	1994-12-19	Composition topique contenant un antagoniste de substance p

Publications (1)

Publication Number	Publication Date
DK0722736T3 true DK0722736T3 (da)	2001-04-02

Family

ID=9469931

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK95402502T DK0722736T3 (da)	1994-12-19	1995-11-09	Topisk sammensætning indeholdende en antagonist for substans P

Country Status (17)

Country	Link
US (2)	US5824650A (da)
EP (1)	EP0722736B1 (da)
JP (1)	JPH08208505A (da)
AR (1)	AR002007A1 (da)
AT (1)	ATE198986T1 (da)
BR (1)	BR9505408A (da)
CA (1)	CA2165521C (da)
DE (1)	DE69520032T2 (da)
DK (1)	DK0722736T3 (da)
ES (1)	ES2157307T3 (da)
FR (1)	FR2728166A1 (da)
GR (1)	GR3035652T3 (da)
HU (1)	HU218936B (da)
MX (1)	MX9505182A (da)
PL (1)	PL311918A1 (da)
PT (1)	PT722736E (da)
RU (1)	RU2124353C1 (da)

Families Citing this family (66)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6203803B1 (en)	1994-12-14	2001-03-20	Societe L'oreal S.A.	Use of a substance P antagonist in a cosmetic composition, and the composition thus obtained
US7404967B2 (en) *	1994-12-21	2008-07-29	Cosmederm, Inc.	Topical product formulations containing strontium for reducing skin irritation
US6139850A (en) *	1994-12-21	2000-10-31	Cosmederm Technologies	Formulations and methods for reducing skin irritation
FR2732221B1 (fr) *	1995-03-28	1997-04-25	Oreal	Utilisation d'un antagoniste de cgrp pour traiter les rougeurs cutanees d'origine neurogene et composition obtenue
US20040071762A1 (en) *	1996-05-29	2004-04-15	Scotia Holdings Plc	Diagnostic test for schizophrenia, using niacin
PE20001420A1 (es)	1998-12-23	2000-12-18	Pfizer	Moduladores de ccr5
US7217714B1 (en)	1998-12-23	2007-05-15	Agouron Pharmaceuticals, Inc.	CCR5 modulators
DE19924277A1 (de) *	1999-05-27	2000-11-30	Beiersdorf Ag	Zubereitungen von Emulsionstyp W/O mit erhöhtem Wassergehalt mit einem Gehalt an mittelpolaren Lipiden und Siliconemulgatoren und gegebenenfalls kationischen Polymeren
US6861397B2 (en) *	1999-06-23	2005-03-01	The Dial Corporation	Compositions having enhanced deposition of a topically active compound on a surface
US6107261A (en) *	1999-06-23	2000-08-22	The Dial Corporation	Compositions containing a high percent saturation concentration of antibacterial agent
US6689399B1 (en)	2000-03-16	2004-02-10	James R. Dickson	Transdermal delivery of an anti-inflammatory composition
US8512718B2 (en)	2000-07-03	2013-08-20	Foamix Ltd.	Pharmaceutical composition for topical application
ITPD20010187A1 (it) *	2001-07-23	2003-01-23	Cutech Srl	Trattamento del follicolo polifero, in particolare contro la caduta dei capelli
US7820186B2 (en) *	2001-12-21	2010-10-26	Galderma Research & Development	Gel composition for once-daily treatment of common acne comprising a combination of benzoyl peroxide and adapalene and/or adapalene salt
US7750052B2 (en) *	2002-01-15	2010-07-06	OOO “Naucho-Proizvodstvennoe Obiedinenie” “Opytnaya Vodno-Analitcheskaya Laboratoria”	Method for producing a water-alcohol solution and products based thereon
JP4473491B2 (ja) *	2002-05-28	2010-06-02	株式会社資生堂	毛穴縮小剤
US6723755B2 (en)	2002-06-12	2004-04-20	Piotr Chomczynski	Method of treating rosacea
IL152486A0 (en)	2002-10-25	2003-05-29	Meir Eini	Alcohol-free cosmetic and pharmaceutical foam carrier
CA2502986C (en)	2002-10-25	2011-08-23	Foamix Ltd.	Cosmetic and pharmaceutical foam
US20080138296A1 (en)	2002-10-25	2008-06-12	Foamix Ltd.	Foam prepared from nanoemulsions and uses
US8900554B2 (en)	2002-10-25	2014-12-02	Foamix Pharmaceuticals Ltd.	Foamable composition and uses thereof
US8119150B2 (en)	2002-10-25	2012-02-21	Foamix Ltd.	Non-flammable insecticide composition and uses thereof
US9211259B2 (en)	2002-11-29	2015-12-15	Foamix Pharmaceuticals Ltd.	Antibiotic kit and composition and uses thereof
US8486376B2 (en)	2002-10-25	2013-07-16	Foamix Ltd.	Moisturizing foam containing lanolin
US10117812B2 (en)	2002-10-25	2018-11-06	Foamix Pharmaceuticals Ltd.	Foamable composition combining a polar solvent and a hydrophobic carrier
US8119109B2 (en)	2002-10-25	2012-02-21	Foamix Ltd.	Foamable compositions, kits and methods for hyperhidrosis
US9668972B2 (en)	2002-10-25	2017-06-06	Foamix Pharmaceuticals Ltd.	Nonsteroidal immunomodulating kit and composition and uses thereof
US9265725B2 (en)	2002-10-25	2016-02-23	Foamix Pharmaceuticals Ltd.	Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US7704518B2 (en)	2003-08-04	2010-04-27	Foamix, Ltd.	Foamable vehicle and pharmaceutical compositions thereof
US7700076B2 (en)	2002-10-25	2010-04-20	Foamix, Ltd.	Penetrating pharmaceutical foam
US7820145B2 (en)	2003-08-04	2010-10-26	Foamix Ltd.	Oleaginous pharmaceutical and cosmetic foam
US7575739B2 (en)	2003-04-28	2009-08-18	Foamix Ltd.	Foamable iodine composition
US8486374B2 (en)	2003-08-04	2013-07-16	Foamix Ltd.	Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
US8795693B2 (en)	2003-08-04	2014-08-05	Foamix Ltd.	Compositions with modulating agents
US6902723B2 (en) *	2003-08-14	2005-06-07	The Gillette Company	Enhanced efficacy antiperspirant compositions containing strontium
US6923952B2 (en) *	2003-08-14	2005-08-02	The Gillette Company	Enhanced efficacy antiperspirant compositions containing strontium or calcium
US7812057B2 (en) *	2004-08-25	2010-10-12	Molecular Research Center, Inc.	Cosmetic compositions
US7872050B2 (en)	2005-03-14	2011-01-18	Yaupon Therapeutics Inc.	Stabilized compositions of volatile alkylating agents and methods of using thereof
US20110039943A1 (en) *	2005-03-14	2011-02-17	Robert Alonso	Methods for treating skin disorders with topical nitrogen mustard compositions
US8501818B2 (en) *	2005-03-14	2013-08-06	Ceptaris Therapeutics, Inc.	Stabilized compositions of alkylating agents and methods of using same
WO2007054818A2 (en)	2005-05-09	2007-05-18	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions thereof
DK1888033T3 (da) *	2005-06-09	2014-05-26	Meda Ab	Fremgangsmåde og sammensætning til behandling af inflammatoriske sygdomme
WO2007062060A2 (en)	2005-11-22	2007-05-31	Ted Reid	Methods and compositions using substance p to promote wound healing
EP2075252B1 (en)	2006-10-16	2015-07-29	Lion Corporation	Nk1 receptor antagonist composition
US20080260655A1 (en)	2006-11-14	2008-10-23	Dov Tamarkin	Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
FR2910321B1 (fr)	2006-12-21	2009-07-10	Galderma Res & Dev S N C Snc	Gel creme comprenant au moins un retinoide et du peroxyde de benzole
JP5693218B2 (ja) *	2007-05-11	2015-04-01	アロエバイオティクス・リサーチ・ラブズ，インコーポレイテッド	皮膚強化用アロエ製剤
US8636982B2 (en)	2007-08-07	2014-01-28	Foamix Ltd.	Wax foamable vehicle and pharmaceutical compositions thereof
US9439857B2 (en)	2007-11-30	2016-09-13	Foamix Pharmaceuticals Ltd.	Foam containing benzoyl peroxide
WO2009072007A2 (en)	2007-12-07	2009-06-11	Foamix Ltd.	Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8518376B2 (en)	2007-12-07	2013-08-27	Foamix Ltd.	Oil-based foamable carriers and formulations
EP2242476A2 (en)	2008-01-14	2010-10-27	Foamix Ltd.	Poloxamer foamable pharmaceutical compositions with active agents and/or therapeutic cells and uses
SI2273876T1 (sl) *	2008-03-27	2019-09-30	Helsinn Healthcare Sa	Stabilizirani sestavki alkilirajočih sredstev in metod za uporabo le-teh
EP2177208A1 (en) *	2008-10-17	2010-04-21	Ferrer Internacional, S.A.	Pharmaceutical topical compositions
US7833829B2 (en) *	2008-10-28	2010-11-16	Honeywell International Inc.	MEMS devices and methods of assembling micro electromechanical systems (MEMS)
TW201034674A (en) *	2009-02-24	2010-10-01	Novartis Ag	Uses of NK receptor antagonists
WO2010125470A2 (en)	2009-04-28	2010-11-04	Foamix Ltd.	Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
CA2769677A1 (en)	2009-07-29	2011-02-03	Foamix Ltd.	Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769625C (en)	2009-07-29	2017-04-11	Foamix Ltd.	Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2776471C (en)	2009-10-02	2019-02-12	Foamix Ltd.	Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en)	2009-10-02	2017-12-26	Foamix Pharmaceuticals Ltd.	Methods for accelerated return of skin integrity and for the treatment of impetigo
RU2485955C2 (ru) *	2010-11-17	2013-06-27	Леонид Леонидович Клопотенко	Фармацевтическая композиция, содержащая флуконазол, и/или кетоконазол, и/или тербинафин и липосомы для местного применения
CN104363901B (zh) *	2012-03-21	2017-03-22	美国考斯麦德生物科技有限公司	局部投与用于治疗疼痛、瘙痒症和炎症的含锶复合物
US11235002B2 (en)	2015-08-21	2022-02-01	Galleon Labs Llc	Strontium based compositions and formulations for pain, pruritus, and inflammation
MX2020012139A (es)	2016-09-08	2021-01-29	Vyne Pharmaceuticals Inc	Composiciones y metodos para tratar rosacea y acne.
US11708135B2 (en)	2018-05-30	2023-07-25	Philip John Milanovich	Waste management system

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
DE297062C (da) *
LU65373A1 (da) *	1972-05-17	1973-11-23
US3772431A (en) *	1972-09-21	1973-11-13	W Mlkvy	Effervescent mouthwash tablet
US3888976A (en) *	1972-09-21	1975-06-10	William P Mlkvy	Zinc and strontium ion containing effervescent mouthwash tablet
US4477439A (en) *	1981-04-13	1984-10-16	Walter J. Monacelli	Treatment of irritated and excoriated areas around the stoma of ostomy patients
JPS5921656A (ja)	1982-07-28	1984-02-03	Takeda Chem Ind Ltd	ポリペプチド誘導体
US4472305A (en)	1983-05-17	1984-09-18	Sterling Drug Inc.	Hexapeptide amides
DE3338957A1 (de) *	1983-10-27	1985-05-15	Keyhan Dipl.-Ing. 6908 Wiesloch Ghawami	Enthaarungsmittel
LU85544A1 (fr)	1984-09-19	1986-04-03	Cird	Derives heterocycliques aromatiques,leur procede de preparation et leur application dans les domaines therapeutique et cosmetique
LU85849A1 (fr)	1985-04-11	1986-11-05	Cird	Derives benzonaphtaleniques,leur procede de preparation et leur application dans les domaines pharmaceutiques et cosmetiques
IT1214611B (it) *	1985-05-22	1990-01-18	Schiena Ricerche	Composti per uso cosmetico dermatologico e relative composizioni.
ATE69954T1 (de) *	1985-10-08	1991-12-15	Psori Med Ag	Salzmischung zur behandlung der schuppenflechte (psoriasis) und anderer hautkrankheiten.
US4986981A (en) *	1986-07-07	1991-01-22	Den Mat Corporation	Toothpaste having low abrasion
US5091171B2 (en) *	1986-12-23	1997-07-15	Tristrata Inc	Amphoteric compositions and polymeric forms of alpha hydroxyacids and their therapeutic use
US4839465A (en)	1987-01-20	1989-06-13	Sterling Drug Inc.	Di-(D-tryptophyl and/or tetrahydropyridoindolylcarbonyl)-containing peptide amides and process for preparation thereof
SE8701372L (sv) *	1987-04-02	1988-10-03	Boliden Ab	Foerfarande och medel foer konservering av hoe
US4931459A (en)	1987-07-14	1990-06-05	Warner-Lambert Company	Method for treating acute respirator distress syndrome
US4910317A (en)	1987-07-14	1990-03-20	Warner-Lambert Company	Benzofurans and benzothiophenes having antiallergic activity and method of use thereof
IE64995B1 (en)	1987-07-14	1995-09-20	Warner Lambert Co	Novel benzothiophenes having antiallergic activity and both novel and other selected benzothiophenes having activity for treating acute respiratory distress syndrome
LU87109A1 (fr)	1988-01-20	1989-08-30	Cird	Esters et thioesters aromatiques,leur procede de preparation et leur utilisation en medecine humaine ou veterinaire et en cosmetique
GB8807921D0 (en)	1988-04-05	1988-05-05	Fujisawa Pharmaceutical Co	Ws-9326 & its derivatives
US5187156A (en)	1988-03-16	1993-02-16	Fujisawa Pharmaceutical Co., Ltd.	Peptide compounds, processes for preparation thereof and pharmaceutical composition comprising the same
GB8807246D0 (en)	1988-03-25	1988-04-27	Merck Sharp & Dohme	Therapeutic agents
EP0360390A1 (en)	1988-07-25	1990-03-28	Glaxo Group Limited	Spirolactam derivatives
DE3929411A1 (de) *	1988-09-22	1990-03-29	Siegfried Natterer	Pharmazeutische zubereitung sowie verfahren zu ihrer herstellung
WO1990005525A1 (en)	1988-11-23	1990-05-31	Pfizer Inc.	Quinuclidine derivatives as substance p antagonists
US5164372A (en)	1989-04-28	1992-11-17	Fujisawa Pharmaceutical Company, Ltd.	Peptide compounds having substance p antagonism, processes for preparation thereof and pharmaceutical composition comprising the same
JPH03119163A (ja)	1989-06-05	1991-05-21	Sequa Chemicals Inc	不織繊維用バインダー
US5202130A (en) *	1989-08-31	1993-04-13	The Johns Hopkins University	Suppression of eczematous dermatitis by calcium transport inhibition
FR2654725B1 (fr)	1989-11-23	1992-02-14	Rhone Poulenc Sante	Nouveaux derives de l'isoindolone, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2654726B1 (fr)	1989-11-23	1992-02-14	Rhone Poulenc Sante	Nouveaux derives de l'isoindolone et leur preparation.
GB8929070D0 (en)	1989-12-22	1990-02-28	Fujisawa Pharmaceutical Co	Peptide compounds,processes for preparation thereof and pharmaceutical composition comprising the same
UA41251C2 (uk)	1990-01-04	2001-09-17	Пфайзер, Інк.	Гідровані азотвмісні гетероциклічні сполуки, похідні піперидину, фармацевтична композиція та спосіб пригнічення активності речовини р в організмі
US5232929A (en)	1990-11-28	1993-08-03	Pfizer Inc.	3-aminopiperidine derivatives and related nitrogen containing heterocycles and pharmaceutical compositions and use
DE59002748D1 (de) *	1990-01-29	1993-10-21	Wogepharm Gmbh	Verfahren zur Herstellung von Mitteln zur Therapie von Hauterkrankungen.
US5321032A (en)	1990-02-15	1994-06-14	Fujisawa Pharmaceutical Co., Ltd.	Peptide compounds and pharmaceutical compositions thereof
US5344532A (en)	1990-03-09	1994-09-06	Joseph Adrian A	Ultrasonic energy producing device
FR2662607B1 (fr) *	1990-05-30	1992-08-28	Oreal	Composition destinee a etre utilisee pour freiner la chute des cheveux et pour induire et stimuler leur croissance, contenant des derives d'alkyl-2 amino-4 (ou dialkyl-2-4) pyrimidine oxyde-3 .
HU226529B1 (en)	1990-05-31	2009-03-30	Pfizer	Process for preparing substituted piperidines
DK0532527T3 (da)	1990-06-01	1995-01-02	Pfizer	3-amino-2-arylquinuclidiner, fremgangsmåde til fremstilling deraf og farmaceutiske præparater indeholdende disse
EP0498069B1 (en)	1990-12-21	1995-10-25	Fujisawa Pharmaceutical Co., Ltd.	New use of peptide derivative
JPH0733385B2 (ja)	1991-01-10	1995-04-12	フアイザー・インコーポレイテツド	物質ｐの拮抗薬としてのｎ−アルキルキヌクリジニウム塩
DE69220258T2 (de)	1991-02-11	1997-12-18	Merck Sharp & Dohme	Azabicyclische Verbindungen, diese enthaltende pharmazeutische Zubereitungen und ihre therapeutische Verwendung
EP0573522B1 (en)	1991-03-01	1994-12-14	Pfizer Inc.	1-azabicyclo[3.2.2]nonan-3-amine derivatives
AU647592B2 (en)	1991-03-26	1994-03-24	Pfizer Inc.	Stereoselective preparation of substituted piperidines
FR2677361A1 (fr)	1991-06-04	1992-12-11	Adir	Nouveaux peptides et pseudopeptides, derives de tachykinines, leur procede de preparation et les compositions pharmaceutiques qui les contiennent.
FR2676443B1 (fr)	1991-05-17	1993-08-06	Rhone Poulenc Rorer Sa	Nouveaux derives de perhydroisoindole et leur preparation.
FR2676446B1 (fr)	1991-05-17	1993-08-06	Rhone Poulenc Rorer Sa	Nouveaux derives du thiopyranopyrrole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2676442B1 (fr)	1991-05-17	1993-08-06	Rhone Poulenc Rorer Sa	Nouveau derives de perhydroisoindole, leur preparation et les compositions pharmaceutiques qui les contiennent.
FR2676447B1 (fr)	1991-05-17	1993-08-06	Rhone Poulenc Rorer Sa	Nouveaux derives du thiopyranopyrrole et leur preparation.
RU2092486C1 (ru)	1991-05-22	1997-10-10	Пфайзер Инк.	Замещенные 3-аминохинуклидины
GB9113219D0 (en)	1991-06-19	1991-08-07	Fujisawa Pharmaceutical Co	Peptide compound,processes for preparation thereof and pharmaceutical composition comprising the same
DE9290083U1 (de)	1991-06-20	1994-02-17	Pfizer Inc., New York, N.Y.	Fluoralkoxybenzylamino-Derivate von stickstoffhaltigen Heterocyclen
TW202432B (da)	1991-06-21	1993-03-21	Pfizer
US5288730A (en)	1991-06-24	1994-02-22	Merck Sharp & Dohme Limited	Azabicyclic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001160A1 (en)	1991-07-05	1993-01-21	Merck Sharp & Dohme Limited	Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001169A2 (en)	1991-07-05	1993-01-21	Merck Sharp & Dohme Limited	Aromatic compounds, pharmaceutical compositions containing them and their use in therapy
WO1993001159A1 (en)	1991-07-10	1993-01-21	Merck Sharp & Dohme Limited	Fused tricyclic compounds, pharmaceutical compositions containing them and their use in therapy
CA2110725A1 (en)	1991-07-10	1993-01-21	Andrew P. Owens	Aromatic compounds, compositions containing them and their use in therapy
MY110227A (en)	1991-08-12	1998-03-31	Ciba Geigy Ag	1-acylpiperindine compounds.
DE69210029T2 (de)	1991-08-20	1997-01-09	Merck Sharp & Dohme	Azacyclische verbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen
BR9206500A (pt)	1991-09-26	1995-10-03	Pfizer	Heterociclos contendo, nitrogênio tricíclico condensado como antagonistas de substancia receptora P
JP2553020B2 (ja)	1991-11-07	1996-11-13	吉富製薬株式会社	キヌクリジン化合物およびその医薬用途
CA2324959C (en)	1991-11-12	2002-11-12	Pfizer Limited	Phthalimido compounds as intermediates for producing substance p receptor antagonists
CA2083891A1 (en)	1991-12-03	1993-06-04	Angus Murray Macleod	Heterocyclic compounds, compositions containing them and their use in therapy
US5569662A (en) *	1992-03-23	1996-10-29	Pfizer Inc.	Quinuclidine derivatives as substance P antagonists
DE4227203C2 (de) *	1992-08-17	1994-03-24	Kao Corp Gmbh	Mittel und Verfahren zur Haarbehandlung
JP2656699B2 (ja)	1992-10-21	1997-09-24	ファイザー製薬株式会社	置換ベンジルアミノキヌクリジン
US5716625A (en) *	1994-12-21	1998-02-10	Cosmederm Technologies	Formulations and methods for reducing skin irritation

1994
- 1994-12-19 FR FR9415253A patent/FR2728166A1/fr active Granted
1995
- 1995-11-09 ES ES95402502T patent/ES2157307T3/es not_active Expired - Lifetime
- 1995-11-09 EP EP95402502A patent/EP0722736B1/fr not_active Revoked
- 1995-11-09 PT PT95402502T patent/PT722736E/pt unknown
- 1995-11-09 DE DE69520032T patent/DE69520032T2/de not_active Revoked
- 1995-11-09 DK DK95402502T patent/DK0722736T3/da active
- 1995-11-09 AT AT95402502T patent/ATE198986T1/de not_active IP Right Cessation
- 1995-12-11 MX MX9505182A patent/MX9505182A/es unknown
- 1995-12-13 BR BR9505408A patent/BR9505408A/pt active Search and Examination
- 1995-12-15 AR ARP950100577A patent/AR002007A1/es unknown
- 1995-12-18 PL PL95311918A patent/PL311918A1/xx unknown
- 1995-12-18 CA CA002165521A patent/CA2165521C/fr not_active Expired - Fee Related
- 1995-12-18 HU HU9503623A patent/HU218936B/hu not_active IP Right Cessation
- 1995-12-18 JP JP7329297A patent/JPH08208505A/ja active Pending
- 1995-12-18 RU RU95121151A patent/RU2124353C1/ru active
- 1995-12-19 US US08/575,682 patent/US5824650A/en not_active Expired - Lifetime
1998
- 1998-06-15 US US09/094,558 patent/US5972892A/en not_active Expired - Lifetime
2001
- 2001-03-29 GR GR20010400502T patent/GR3035652T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
FR2728166B1 (da)	1997-02-07
HUT74830A (en)	1997-02-28
US5972892A (en)	1999-10-26
MX9505182A (es)	1997-02-28
JPH08208505A (ja)	1996-08-13
RU2124353C1 (ru)	1999-01-10
ES2157307T3 (es)	2001-08-16
HU218936B (hu)	2001-01-29
US5824650A (en)	1998-10-20
CA2165521A1 (fr)	1996-06-20
EP0722736A1 (fr)	1996-07-24
FR2728166A1 (fr)	1996-06-21
HU9503623D0 (en)	1996-02-28
GR3035652T3 (en)	2001-06-29
AR002007A1 (es)	1998-01-07
PT722736E (pt)	2001-05-31
BR9505408A (pt)	1997-10-28
PL311918A1 (en)	1996-06-24
ATE198986T1 (de)	2001-02-15
DE69520032T2 (de)	2001-05-23
DE69520032D1 (de)	2001-03-08
CA2165521C (fr)	2002-07-16
EP0722736B1 (fr)	2001-01-31

Publication	Publication Date	Title
DK0722736T3 (da)	2001-04-02	Topisk sammensætning indeholdende en antagonist for substans P
FI973518A (fi)	1997-08-27	Farmaseuttinen koostumus piperidinoalkanoliyhdisteille
BR9509200A (pt)	1997-12-30	Composição de matéria
DE69530821D1 (de)	2003-06-26	Klebebandzusammensetzung
NO973479L (no)	1997-09-29	Substituerte heterosykliske forbindelser, fremgangsmåte for fremstilling og farmasöytiske blandinger inneholdende samme
PT892640E (pt)	2004-06-30	Composicoes farmaceuticas de micofenolato entericamente revestidas
ID19755A (id)	1998-07-30	Komposisi untuk pemberian transdermal obat-obat steroid
FR2740682B1 (fr)	1997-12-05	Composition topique contenant de la capsazepine
DK0797551T3 (da)	2002-02-25	Cementagtig sammensætning
DE69523022D1 (de)	2001-11-08	Verdickungsmittel enthaltende topische zusammensetzung
FI930656A (fi)	1993-08-25	Komposition foer nasal behandling
DE69827744D1 (de)	2004-12-30	Polybuten-1 enthaltende polyolefinzusammensetzung
BR9505382A (pt)	1997-10-28	Utilização de ao menos um antagonista de substáncia P
ID21009A (id)	1999-04-08	Komposisi untuk supositori
NO973575L (no)	1997-08-04	Ny konserveringsmiddelsammensetning
ID17561A (id)	1998-01-08	Komposisi untuk pemakaian luar
ID18832A (id)	1998-05-14	Komposisi insektisida
BR9507768A (pt)	1997-09-02	Composição farmacêutica
FI973229A0 (fi)	1997-08-05	Uusi farmaseuttinen koostumus
EE9900206A (et)	1999-12-15	N-sulfonüülindoliiniderivaate sisaldavad farmatseutilised kompositsioonid
ID16838A (id)	1997-11-13	Komposisi dekafluoropentana
DE69605016D1 (de)	1999-12-09	Intumeszenzzusammensetzung
BR9505392A (pt)	1997-10-28	Utilizações de ao menos um antagonista de substância P
DE69528771D1 (de)	2002-12-12	Silicon enthaltende imidazolinzusammensetzungen
IT1280428B1 (it)	1998-01-20	Composizione farmaceutica per uso topico